R&D Systems™ Recombinant Human IL-27 Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human IL-27 Protein is derived from NS0. The Recombinant Human IL-27 Protein has been validated for the following applications: Bioactivity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in HEPES, NaCl, EDTA and CHAPS with BSA as a carrier protein.
• Gene ID (Entrez): 246778
• Molecular Weight (g/mol): Observed M.W.: 60 kDa, under reducing conditions.
• Name: IL-27
• Quantity: 10 μg
• Source: Mouse myeloma cell line, NS0-derived human IL-27 protein Human IL-27 EBI-3 (Arg21-Lys229) (N-terminus) Accession # Q14213.2 Human IL-27 p28 (Phe29-Pro243) (N-terminus) Accession # AAM34498.1 6-His tag(C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: 90%, by SDS-PAGE under reducing conditions and visualized by silver stain.